These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 34646137)

  • 21. Coprescription of Chinese Herbal Medicine and Western Medications among Prostate Cancer Patients: A Population-Based Study in Taiwan.
    Lin YH; Chen KK; Chiu JH
    Evid Based Complement Alternat Med; 2012; 2012():147015. PubMed ID: 21792368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of Chinese Herbal Medicines Is Related to a Reduction in Depression Risk Among Patients With Insomnia: A Matched Cohort Study.
    Chiao YW; Livneh H; Guo HR; Chen WJ; Lu MC; Lin MC; Yeh CC; Tsai TY
    Front Neurol; 2020; 11():583485. PubMed ID: 33551951
    [No Abstract]   [Full Text] [Related]  

  • 23. Integrating Chinese Herbal Medicine into Conventional Care Was Related to Lower Risk of Sarcopenia Among Rheumatid Arthritis Patients: A Retrospective, Population-Based Study.
    Li HH; Livneh H; Huang HL; Wang YH; Lu MC; Chen WJ; Tsai TY
    J Multidiscip Healthc; 2023; 16():3117-3127. PubMed ID: 37901596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statin reduces mortality and morbidity in systemic lupus erythematosus patients with hyperlipidemia: A nationwide population-based cohort study.
    Yu HH; Chen PC; Yang YH; Wang LC; Lee JH; Lin YT; Chiang BL
    Atherosclerosis; 2015 Nov; 243(1):11-8. PubMed ID: 26342937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved Survival With Integration of Chinese Herbal Medicine Therapy in Patients With Acute Myeloid Leukemia: A Nationwide Population-Based Cohort Study.
    Fleischer T; Chang TT; Chiang JH; Sun MF; Yen HR
    Integr Cancer Ther; 2017 Jun; 16(2):156-164. PubMed ID: 27531548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of Chinese herbal medicines by rheumatoid arthritis patients was associated with lower risk of stroke: A retrospective cohort study.
    Lai NS; Livneh H; Fan YH; Lu MC; Liao HH; Tsai TY
    Complement Ther Med; 2019 Aug; 45():124-129. PubMed ID: 31331548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Chinese herbal medicines on dementia risk in patients with sleep disorders in Taiwan.
    Chen CJ; Liu X; Chiou JS; Hang LW; Li TM; Tsai FJ; Ko CH; Lin TH; Liao CC; Huang SM; Liang WM; Lin YJ
    J Ethnopharmacol; 2021 Jan; 264():113267. PubMed ID: 32822822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjunctive Chinese Herbal Medicine Treatment is Associated With an Improved Survival Rate in Patients With Cervical Cancer in Taiwan: A Matched Cohort Study.
    Wang C; Lin KY; Wu MY; Lin CL; Lin JG; Chang CY; Lin WC; Yen HR
    Integr Cancer Ther; 2021; 20():15347354211061752. PubMed ID: 34923874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Comparison of the Risk of Fracture in Rheumatoid Arthritis Patients with and without Receiving Chinese Herbal Medicine.
    Liao HH; Livneh H; Chung YJ; Lin CH; Lai NS; Yen HR; Tsai TY
    J Multidiscip Healthc; 2021; 14():3399-3409. PubMed ID: 34934326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chinese Herbal Medicine Improved Survival in Stage IV Breast Cancer Patients: Data Mining of the Incorporated Taiwan Cancer Registry Database and Hospital Database.
    Chen PE; Hung HH; Huang WT; Yeh CH; Kao YW; Shia BC; Huang ST
    Integr Cancer Ther; 2023; 22():15347354231178898. PubMed ID: 37278256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The characteristics and prescription patterns of Chinese herbal medicine in clinical practice for the treatment of anemia.
    Chen WD; Huang HS; Su YC; Chou SC; Ho WC; Kao MC; Lin HJ; Huang ST
    Taiwan J Obstet Gynecol; 2018 Aug; 57(4):570-577. PubMed ID: 30122581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations between prescribed Chinese herbal medicine and risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide population-based cohort study.
    Tsai TY; Livneh H; Hung TH; Lin IH; Lu MC; Yeh CC
    BMJ Open; 2017 Jan; 7(1):e014571. PubMed ID: 28122837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased risk of chronic obstructive pulmonary disease in patients with systemic lupus erythematosus: a population-based cohort study.
    Shen TC; Lin CL; Chen CH; Tu CY; Hsia TC; Shih CM; Hsu WH; Chang YJ
    PLoS One; 2014; 9(3):e91821. PubMed ID: 24622340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chinese Herbal Medicine Improves the Long-Term Survival Rate of Patients With Chronic Kidney Disease in Taiwan: A Nationwide Retrospective Population-Based Cohort Study.
    Huang KC; Su YC; Sun MF; Huang ST
    Front Pharmacol; 2018; 9():1117. PubMed ID: 30327604
    [No Abstract]   [Full Text] [Related]  

  • 35. Chinese Herbal Medicine as an Adjunctive Therapy Improves the Survival Rate of Patients with Ischemic Heart Disease: A Nationwide Population-Based Cohort Study.
    Hung IL; Chung CJ; Hu WL; Liao YN; Hsu CY; Chiang JH; Hung YC
    Evid Based Complement Alternat Med; 2022; 2022():5596829. PubMed ID: 35832512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adding Chinese Herbal Medicine to Routine Care is Associated With a Lower Risk of Rheumatoid Arthritis Among Patients With Asthma: A Population-Based Retrospective Cohort Study.
    Chang WC; Livneh H; Chen WJ; Hsieh CC; Wang YH; Lu MC; Guo HR; Tsai TY
    Front Pharmacol; 2022; 13():895717. PubMed ID: 36059972
    [No Abstract]   [Full Text] [Related]  

  • 37. Chinese Herbal Medicine Decreases Incidence of Cirrhosis in Patients with Non-Alcoholic Fatty Liver Disease in Taiwan: A Propensity Score-Matched Cohort Study.
    Huang CY; Wu MY; Wang HC; Liao YC; Tou SI; Yen HR
    J Altern Complement Med; 2021 Jul; 27(7):596-605. PubMed ID: 33913734
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of Chinese herbal medicines on the occurrence of diabetic retinopathy in type 2 diabetes patients and protection of ARPE-19 retina cells by inhibiting oxidative stress.
    Tsai FJ; Li TM; Ko CH; Cheng CF; Ho TJ; Liu X; Tsang H; Lin TH; Liao CC; Li JP; Huang SM; Lin JC; Lin CC; Liang WM; Lin YJ
    Oncotarget; 2017 Sep; 8(38):63528-63550. PubMed ID: 28969009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of progression from newly diagnosed systemic lupus erythematosus to end stage renal disease and all-cause mortality: a nationwide cohort study in Taiwan.
    Lin WH; Guo CY; Wang WM; Yang DC; Kuo TH; Liu MF; Wang MC
    Int J Rheum Dis; 2013 Dec; 16(6):747-53. PubMed ID: 24382283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of end-stage renal disease in systemic lupus erythematosus patients: a nationwide population-based study.
    Yu KH; Kuo CF; Chou IJ; Chiou MJ; See LC
    Int J Rheum Dis; 2016 Nov; 19(11):1175-1182. PubMed ID: 26864331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.